{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T23:25:32Z","timestamp":1788650732429,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.pharep.2017.06.012","type":"journal-article","created":{"date-parts":[[2017,6,27]],"date-time":"2017-06-27T03:47:32Z","timestamp":1498535252000},"page":"1254-1262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Apigenin, a novel candidate involving herb-drug interaction (HDI), interacts with organic anion transporter 1 (OAT1)"],"prefix":"10.1007","volume":"69","author":[{"given":"Ting","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiasheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimin","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingzheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxin","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"1","key":"10.1016\/j.pharep.2017.06.012_bib0005","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1152\/physrev.00025.2013","article-title":"The organic anion transporter (OAT) family: a systems biology perspective","volume":"95","author":"Nigam","year":"2015","journal-title":"Physiol Rev"},{"issue":"8","key":"10.1016\/j.pharep.2017.06.012_bib0010","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1124\/dmd.106.013912","article-title":"Human organic Anion transporters 1 (hOAT1\/SLC22A6) and 3 (hOAT3\/SLC22A8) transport edaravone (MCI-186; 3-methyl-1phenyl-2-pyrazolin-5-one) and its sulfate conjugate","volume":"35","author":"Mizuno","year":"2007","journal-title":"Drug Metab Dispos"},{"issue":"201","key":"10.1016\/j.pharep.2017.06.012_bib0015","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-3-642-14541-4_2","article-title":"In vitro and in vivo evidence of the importance of organic anion transporters (OATs) in drug therapy","author":"Burckhardt","year":"2011","journal-title":"Handb Exp Pharmacol"},{"issue":"9","key":"10.1016\/j.pharep.2017.06.012_bib0020","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1124\/dmd.114.059337","article-title":"Flavonoids are inhibitors of human organic anion transporter 1 (OAT1)-mediated transport","volume":"42","author":"An","year":"2014","journal-title":"Drug Metab Dispos"},{"issue":"6","key":"10.1016\/j.pharep.2017.06.012_bib0025","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.phrs.2007.08.007","article-title":"Interaction characteristics of flavonoids with human organic anion transporter 1 (hOAT1) and 3 (hOAT3)","volume":"56","author":"Hong","year":"2007","journal-title":"Pharmacol Res"},{"issue":"2","key":"10.1016\/j.pharep.2017.06.012_bib0030","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S1734-1140(13)71026-0","article-title":"Benzylpenicillin inhibits the renal excretion of acyclovir by OAT1 and OAT3","volume":"65","author":"Ye","year":"2013","journal-title":"Pharmacol Rep"},{"issue":"8","key":"10.1016\/j.pharep.2017.06.012_bib0035","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.3390\/toxins2082055","article-title":"Assessment of the role of renal organic anion transporters in drug-induced nephrotoxicity","volume":"2","author":"Hagos","year":"2010","journal-title":"Toxins (Basel)"},{"issue":"59","key":"10.1016\/j.pharep.2017.06.012_bib0040","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejps.2014.04.004","article-title":"Inhibitory effects of p-aminohippurate and probenecid on the renal clearance of adefovir and benzylpenicillin as probe drugs for organic anion transporter (OAT) 1 and OAT3 in humans","volume":"1","author":"Maeda","year":"2014","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"10.1016\/j.pharep.2017.06.012_bib0045","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0022-3565(24)38862-7","article-title":"Nonsteroidal anti-inflammatory drugs efficiently reduce the transport and cytotoxicity of adefovir mediated by the human renal organic anion transporter 1","volume":"295","author":"Mulato","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"10.1016\/j.pharep.2017.06.012_bib0050","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1021\/mp100418u","article-title":"Critical role of organic anion transporters 1 and 3 in kidney accumulation and toxicity of aristolochic acid I","volume":"8","author":"Xue","year":"2011","journal-title":"Mol Pharm"},{"issue":"1","key":"10.1016\/j.pharep.2017.06.012_bib0055","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.tiv.2014.10.019","article-title":"Intracellular concentrations determine the cytotoxicity of adefovir, cidofovir and tenofovir","volume":"29","author":"Zhang","year":"2015","journal-title":"Toxicol in Vitro"},{"issue":"8","key":"10.1016\/j.pharep.2017.06.012_bib0060","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1177\/0960327111424302","article-title":"Organic anion transporter 1 (OAT1) involved in renal cell transport of aristolochic acid I","volume":"31","author":"Zeng","year":"2012","journal-title":"Hum Exp Toxicol"},{"issue":"9","key":"10.1016\/j.pharep.2017.06.012_bib0065","doi-asserted-by":"crossref","first-page":"831","DOI":"10.3109\/00498254.2015.1129080","article-title":"The inhibitory effects of camptothecin (CPT) and its derivatives on the substrate uptakes mediated by human solute carrier transporters (SLCs)","volume":"46","author":"Zheng","year":"2017","journal-title":"Xenobiotica"},{"issue":"1-2","key":"10.1016\/j.pharep.2017.06.012_bib0070","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ejps.2012.02.014","article-title":"Inhibition of hepatic uptake transporters by flavonoids","volume":"46","author":"Mandery","year":"2012","journal-title":"Eur J Pharm Sci"},{"issue":"11","key":"10.1016\/j.pharep.2017.06.012_bib0075","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1016\/j.bcp.2010.08.008","article-title":"Influence of the flavonoids apigenin, kaempferol, and quercetin on the function of organic anion transporting polypeptides 1A2 and 2B1","volume":"80","author":"Mandery","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharep.2017.06.012_bib0080","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jchromb.2015.11.024","article-title":"Transporter modulation by Chinese herbal medicines and its mediated pharmacokinetic herb\u2013drug interactions","volume":"1026","author":"Wu","year":"2016","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"7","key":"10.1016\/j.pharep.2017.06.012_bib0085","first-page":"992","article-title":"Interaction of five anthraquinones from rhubarb with human organic anion transporter 1 (SLC22A6) and 3 (SLC22A8) and drug\u2013drug interaction in rats","volume":"38","author":"Ma","year":"2015","journal-title":"J Ethnopharmacol"},{"issue":"7","key":"10.1016\/j.pharep.2017.06.012_bib0090","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.bcp.2011.01.004","article-title":"Flavonoid conjugates interact with organic anion transporters (OATs) and attenuate cytotoxicity of adefovir mediated by organic anion transporter 1 (OAT1\/SLC22A6)","volume":"81","author":"Wong","year":"2011","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"10.1016\/j.pharep.2017.06.012_bib0095","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.3390\/v7041613","article-title":"Apigenin restricts FMDV infection and inhibits viral IRES driven translational activity","volume":"7","author":"Qian","year":"2015","journal-title":"Viruses"},{"issue":"7","key":"10.1016\/j.pharep.2017.06.012_bib0100","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1248\/bpb.b15-00217","article-title":"Time-Dependent Inhibition of hOAT1 and hOAT3 by Anthraquinones","volume":"38","author":"Ma","year":"2015","journal-title":"Biol Pharm Bull"},{"issue":"11","key":"10.1016\/j.pharep.2017.06.012_bib0105","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1021\/mp300365t","article-title":"Potent inhibitors of human organic anion transporters 1 and 3 from clinical drug libraries: discovery and molecular characterization","volume":"9","author":"Duan","year":"2012","journal-title":"Mol Pharm"},{"issue":"2","key":"10.1016\/j.pharep.2017.06.012_bib0110","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ejps.2012.06.004","article-title":"Inhibitory effect of JBP485 on renal excretion of acyclovir by the inhibition of OAT1 and OAT3","volume":"47","author":"Ye","year":"2012","journal-title":"Eur J Pharm Sci"},{"issue":"120","key":"10.1016\/j.pharep.2017.06.012_bib0115","first-page":"2180","article-title":"Flavonoids components analysis of ten different kind of nectar honey by UPLC-MS\/MS","volume":"36","author":"Wang","year":"2016","journal-title":"Chin J Pharm Anal"},{"issue":"11","key":"10.1016\/j.pharep.2017.06.012_bib0120","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1002\/jps.23727","article-title":"The Inhibitory effects of the bioactive components isolated from scutellaria baicalensis on the cellular uptake mediated by the essential solute carrier transporters","volume":"102","author":"Xu","year":"2013","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.pharep.2017.06.012_bib0125","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1146\/annurev-pharmtox-010611-134529","article-title":"Drug transporters in drug efficacy and toxicity","volume":"52","author":"DeGorter","year":"2012","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"2","key":"10.1016\/j.pharep.2017.06.012_bib0130","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ejps.2012.06.004","article-title":"Inhibitory effect of JBP485 on renal excretion of acyclovir by the inhibition of OAT1 and OAT3","volume":"47","author":"Ye","year":"2012","journal-title":"Eur J Pharm Sci"},{"issue":"81","key":"10.1016\/j.pharep.2017.06.012_bib0135","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejps.2015.10.008","article-title":"Bezafibrate\u2013mizoribine interaction: involvement of organic anion transporters OAT1 and OAT3 in rats","volume":"1","author":"Feng","year":"2016","journal-title":"Eur J Pharm Sci"},{"issue":"21","key":"10.1016\/j.pharep.2017.06.012_bib0140","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1021\/acs.jafc.6b00766","article-title":"Chrysin, abundant in morinda citrifolia fruit water-etoac extracts, combined with apigenin synergistically induced apoptosis and inhibited migration in human breast and liver cancer cells","volume":"64","author":"Huang","year":"2016","journal-title":"J Agric Food Chem"},{"issue":"2","key":"10.1016\/j.pharep.2017.06.012_bib0145","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1365-2125.2009.03572.x","article-title":"Time-dependent inhibition (TDI) of CYP3A4 and CYP2C9 by noscapine potentially explains clinical noscapine-warfarin interaction","volume":"69","author":"Fang","year":"2010","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.pharep.2017.06.012_bib0150","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1124\/mol.104.007583","article-title":"The role of N-linked glycosylation in protein folding, membrane targeting, and substrate binding of human organic anion transporter hOAT4","volume":"67","author":"Zhou","year":"2005","journal-title":"Mol Pharmacol"},{"issue":"15","key":"10.1016\/j.pharep.2017.06.012_bib0155","doi-asserted-by":"crossref","first-page":"14961","DOI":"10.1074\/jbc.M400197200","article-title":"Role of glycosylation in the organic anion transporter OAT1","volume":"279","author":"Tanaka","year":"2004","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.pharep.2017.06.012_bib0160","doi-asserted-by":"crossref","first-page":"486","DOI":"10.2133\/dmpk.DMPK-11-RG-020","article-title":"Inhibitory effect of caffeic acid on human organic anion transporters hOAT1 and hOAT3: a novel candidate for food\u2013drug interaction","volume":"26","author":"Uwai","year":"2011","journal-title":"Drug Metab Pharmacokinet"},{"issue":"8","key":"10.1016\/j.pharep.2017.06.012_bib0165","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1007\/s12272-001-1270-x","article-title":"Protective effect of morin on the imipenem-induced nephrotoxicity in rabbits","volume":"31","author":"Lim","year":"2008","journal-title":"Arch Pharm Res"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114017300270?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114017300270?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:37:14Z","timestamp":1752611834000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2017.06.012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S1734114017300270"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2017.06.012","relation":{},"ISSN":["1734-1140"],"issn-type":[{"value":"1734-1140","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Apigenin, a novel candidate involving herb-drug interaction (HDI), interacts with organic anion transporter 1 (OAT1)","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2017.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Sp. z o.o. All rights reserved.","name":"copyright","label":"Copyright"}]}}